Do you have the same question? Follow this Question
May 13, 2026 - 08:33 AM
We’ve provided several answers to questions related to Inlyta (Axitinib) , see some other helpful Q&A related to this product.
Question: Should women who are pregnant or breastfeeding use this medication?
Answer: Women who are pregnant or breastfeeding should not use it unless their doctor approves it. This precaution helps protect the health of both the mother and the child, as certain medications can be harmful during pregnancy or breastfeeding.
Question: What is the standard dosage for this medication in treating renal cell carcinoma?
Answer: The standard dosage is 5mg taken twice daily, with each dose 12 hours apart. Having a set dosing schedule supports consistent medication levels in the body, which is important for effectiveness.
